Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

POLARCOOL Aktie

>POLARCOOL Performance
1 Woche: -19,4%
1 Monat: +9,6%
3 Monate: -4,6%
6 Monate: -35,6%
1 Jahr: -46,1%
laufendes Jahr: -4,6%
>POLARCOOL Aktie
Name:  POLARCOOL AB
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0023467162 / A40X5V
Symbol/ Ticker:  98H0 (Frankfurt)
Kürzel:  FRA:98H0, ETR:98H0, 98H0:GR
Index:  -
Webseite:  https://www.polarcool.se/
Profil:  PolarCool AB is a Swedish medical device company specializing in controlled cooling treatments, particularly for sports medicine. The company develops and markets the PolarCap System, a medical device designed to provide acute treatment for concussiv..
>Volltext..
Marktkapitalisierung:  3.13 Mio. EUR
Unternehmenswert:  3 Mio. EUR
Umsatz:  0.22 Mio. EUR
EBITDA:  -1.35 Mio. EUR
Nettogewinn:  -1.57 Mio. EUR
Gewinn je Aktie:  -0.26 EUR
Schulden:  -
Liquide Mittel:  0.13 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  0.37
Umsatzwachstum:  15.05%
Gewinnwachstum:  -51.74%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  POLARCOOL
Letzte Datenerhebung:  06.04.26
>POLARCOOL Kennzahlen
Aktien/ Unternehmen:
Aktien: 11.62 Mio. St.
Frei handelbar: 99.58%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 3
Umsatz/Mitarb.: 0.07 Mio. EUR
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 6.87
KBV: 1.33
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -695.43%
Gewinnmarge: -697.99%
Operative Marge: -695.43%
Managementeffizenz:
Gesamtkaprendite: -103.95%
Eigenkaprendite: -130.04%
>POLARCOOL Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
26.03.26 - 10:01
Achilles Capital AB (publ.) increases its ownership in PolarCool through the acquisition of 100,000 shares (Cision)
 
The med-tech company PolarCool AB (publ.) announces that Achilles Capital AB has purchased an additional 100,000 shares, corresponding to approximately 1% of the company. Following the transaction, Achilles Capital will own approximately 26.5% of the shares in PolarCool. PolarCool's CEO Erik Andersson comments: -We are glad that our major shareholder Achilles Capital has chosen to acquire an additional 100,000 shares, thereby increasing its ownership in the company. This is a clear vote of confidence in what we are doing and shows that they recognize the company's significant...
06.03.26 - 16:18
PolarCool Completes MDSAP Process Enabling Application for Product Approval in Canada (Cision)
 
The med-tech company PolarCool AB (publ.) has received its MDSAP approval (Medical Device Single Audit Program) following the successful completion of Stage 1 and Stage 2 audits conducted by Intertek. The MDSAP process is therefore finalized, and PolarCool can now proceed with the application for market approval of PolarCap® in Canada. The MDSAP approval means that PolarCool as a company is approved to launch products in several markets outside Europe, such as Canada, the United States, and Australia, among others. The approval replaces separate approvals of the company's quality...
17.02.26 - 10:06
PolarCool Signs Agreement in Finland with Ice Hockey Club Ilves (Cision)
 
The med-tech company PolarCool AB (publ.) has signed an agreement with Finnish Liiga club Ilves for the implementation of PolarCap® as part of the club's concussion management protocol. The agreement further strengthens PolarCool's presence in Finland's top division, Liiga, where the company already collaborates with Rauman Lukko and KalPa. With Ilves joining, PolarCool now partners with three of the league's 16 teams. PolarCool maintains a strong market position within professional ice hockey across Europe, with agreements in all major leagues. In addition, the company holds a league-...
12.02.26 - 10:01
PolarCool Signs Its Third Agreement in the British Elite Ice Hockey League with Manchester Storm (Cision)
 
The med-tech company PolarCool AB (publ.) has entered into an agreement with the professional ice hockey team Manchester Storm in the British Elite Ice Hockey League (EIHL). The club becomes the third team in the league to use PolarCap® for the acute treatment of concussions.   With Manchester Storm as a new customer, PolarCool further expands its presence in the British top league, which consists of a total of ten teams from England, Northern Ireland, Scotland, and Wales. PolarCool already has agreements in place with Cardiff Devils and Sheffield Steelers for the use of PolarCap®....
28.07.25 - 11:18
XFRA: SPAFR - HANDELSUNTERBRECHUNG IN DIVERSEN AUSLANDSAKTIEN - TEIL 13 (XETRA)
 
SE0022060513 SE0022087649 SE0022239950 SE0022574331 SE0022726311 SE0022726485 SE0023287339 SE0023440557 SE0023440763 SE0023467162 SE0023468400 SE0023469200 SE0023595459 SE0025010671 SG1I77884290 SG1J26887955 SG1Q02920318 SG1T74931364 SG2F24986083 SGXE83751573 SGXE91187273 US0512761034 US36268T2069 US37960G4010 US67575Y1091 US9569251013 VGG0103J1075 VGG118701058 VGG3036T1012 VGG4001R1047 VGG4164C1005 VGG4392T1075 ZAE000259701...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!